%0 Generic
%A Choy, J.
%A Suarez Rodriguez, C.
%A Larkin, J.
%A Patel, P.
%A Perez Valderrama, B.
%A Rodriguez-Vida, A.
%A Glen, H.
%A Thistlethwaite, F.
%A Ralph, C.
%A Srinivasan, G.
%A Mendez Vidal, M. J.
%A Carter, A.
%A Tyson, C.
%A Prendergast, A.
%A Mousa, K.
%A Powles, T. B.
%A Szabados, B. E.
%T Outcomes with durvalumab and savolitinib in metastatic papillary renal cancer (mPRC) according to international metastatic renal cell carcinoma database consortium (IMDC) risk groups
%D 2020
%@ 0923-7534
%U https://hdl.handle.net/10668/27421
%~